Ondrey Aaron, CFO of Rocket Pharmaceuticals ($RCKT), made two open market sales of company shares over the past year, totaling about $44,000. His most recent sale occurred on July 3, 2025. These transactions rank 10,529th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. Aaron recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 3, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Ondrey Aaron | Chief Financial Officer | S | Common Stock | 1477 | $2.88 | 128,173.0000 | 94,807,773 | 1.14% | 0.00% |
| April 4, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Ondrey Aaron | Chief Financial Officer | S | Common Stock | 7489 | $5.29 | 129,650.0000 | 94,807,773 | 5.46% | 0.01% |
| Feb. 11, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Ondrey Aaron | Chief Financial Officer | A | Common Stock | 90358 | $0.00 | 137,139.0000 | 94,807,773 | 193.15% | 0.10% |
| Feb. 11, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Ondrey Aaron | Chief Financial Officer | A | Stock Option (Right to Buy) | 134642 | $0.00 | 134,642.0000 | 94,807,773 | 9999.99% | 0.14% |
| April 1, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Ondrey Aaron | Chief Financial Officer | A | Common Stock | 46781 | $0.00 | 46,781.0000 | 84,009,004 | 9999.99% | 0.06% |
| April 1, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Ondrey Aaron | Chief Financial Officer | A | Stock Option (Right to Buy) | 69337 | $0.00 | 69,337.0000 | 84,009,004 | 9999.99% | 0.08% |